carvedilol has been researched along with Cancer of Liver in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " First-line therapies include carvedilol or propranolol to prevent variceal bleeding, lactulose for hepatic encephalopathy, combination aldosterone antagonists and loop diuretics for ascites, and terlipressin for hepatorenal syndrome." | 5.41 | Diagnosis and Management of Cirrhosis and Its Complications: A Review. ( Parikh, ND; Tapper, EB, 2023) |
| " GNPs were identified within the cell near to the nucleus when combined with carvedilol." | 1.48 | Apoptosis in human liver carcinoma caused by gold nanoparticles in combination with carvedilol is mediated via modulation of MAPK/Akt/mTOR pathway and EGFR/FAAD proteins. ( Araújo, AA; Brito, GAC; Cavalcante, RS; Chan, AB; Cruz, LJ; De Araújo, RF; De Castro Miguel, E; Gasparotto, LHS; Guedes, PMM; Pessoa, JB; Silva, HFO, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sinha, R | 1 |
| Tapper, EB | 1 |
| Parikh, ND | 1 |
| De Araújo, RF | 1 |
| Pessoa, JB | 1 |
| Cruz, LJ | 1 |
| Chan, AB | 1 |
| De Castro Miguel, E | 1 |
| Cavalcante, RS | 1 |
| Brito, GAC | 1 |
| Silva, HFO | 1 |
| Gasparotto, LHS | 1 |
| Guedes, PMM | 1 |
| Araújo, AA | 1 |
1 review available for carvedilol and Cancer of Liver
| Article | Year |
|---|---|
Diagnosis and Management of Cirrhosis and Its Complications: A Review.
Topics: Adult; Ascites; Carvedilol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Enc | 2023 |
2 other studies available for carvedilol and Cancer of Liver
| Article | Year |
|---|---|
Exploring the potential chemoprophylactic role of carvedilol for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Carvedilol; Humans; Liver Neoplasms | 2022 |
Apoptosis in human liver carcinoma caused by gold nanoparticles in combination with carvedilol is mediated via modulation of MAPK/Akt/mTOR pathway and EGFR/FAAD proteins.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carbazoles; Carvedilol; ErbB Receptors; G | 2018 |